Pulsed Field Ablation Market: Revolutionizing Treatment with Precision
The Pulsed Field Ablation Market is driven by growing prevalence of cardiovascular diseases
Pulsed field ablation utilizes pulsed electric fields to non-thermally ablate cardiac tissue, making it a minimally invasive alternative treatment for cardiac arrhythmias. It employs an irrigated catheter equipped with electrodes that are placed inside the heart to deliver pulsed electric fields in the range of 1,000-3,000 volts/centimeter. This causes dielectric breakdown of cell membranes, inducing irreversible electroporation and cell death, thereby stopping abnormal electrical signals from disturbing the regular heart rhythm. Compared to radiofrequency ablation and cryoablation, pulsed field ablation achieves faster, larger and more predictable lesion formation without generating heat that can potentially damage collateral tissues.
The Global Pulsed Field Ablation Market is estimated to be valued at USD 106.1 Million in 2024 and is expected to reach USD 1,122.1 Million by 2031, growing at a compound annual growth rate (CAGR) of 40.1% from 2024 to 2031.
Major players in the Pulsed Field Ablation Market are focusing on expanding their geographic presence by targeting emerging economies in Asia Pacific and Latin America. For instance, in 2021, Medtronic received approval to market its Pulsed Field Ablation System in Japan and Australia. Meanwhile, Boston Scientific aims to increase its footprint in China through strategic partnerships with local players. This is expected to significantly boost the overall revenues for pulsed field ablation globally over the coming years.
Get More Insights On- Pulsed Field Ablation Market
Get This Report in Japanese Language: パルスフィールドアブレーション市場
Get This Report in Korean Language: 펄스 필드 절제 시장
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian